The Netflix logo is displayed on one of their buildings in Los Angeles, California. Netflix, the streaming giant, experienced a decline of nearly 7% in its stock price after reporting mixed quarterly results. The company posted earnings of $3.29 per share on $8.19 billion in revenue, surpassing analysts’ expectations. However, analysts had anticipated earnings of …
Johnson & Johnson, a leading healthcare company, reported second-quarter revenue and adjusted earnings that surpassed Wall Street’s expectations. This impressive performance was driven by strong sales from the company’s medtech business, which offers surgical, orthopedic, and vision devices. The increased demand for non-urgent surgeries among older adults, who postponed these procedures during the COVID-19 pandemic, …
Pavlo Gonchar | LightRocket | Getty Images Johnson & Johnson filed a lawsuit against the Biden administration on Tuesday regarding Medicare’s new authority to reduce drug prices. This marks the third pharmaceutical company to challenge this controversial provision of the Inflation Reduction Act. The lawsuit, which was filed in a federal district court in New …
FDA Issues ‘Most Serious’ Recall of Johnson and Johnson Surgical Tools Linked to Patient Burns and Risks By Emily Joshu Health Reporter For Dailymail.Com Updated: 22:25 BST, 11 July 2023 Nationwide recall of Johnson & Johnson surgical tools due to increased risk of injury and death. The Food and Drug Administration (FDA) has categorized this …
Every weekday, the CNBC Investing Club hosted by Jim Cramer presents a “Morning Meeting” livestream at 10:20 a.m. ET. Let’s recap the key moments from Monday’s session. 1. Earnings and Inflation: U.S. stocks experienced a slight uptick on Monday, with the Dow gaining over 150 points. This rally came after a challenging week for major …
During morning trading on April 10, 2023, traders can be seen working on the floor of the New York Stock Exchange. Michael M. Santiago | Getty Images The Biden administration is facing legal action from the pharmaceutical industry’s largest lobbying group, along with two other organizations, over Medicare’s new authority to lower drug prices for …
If someone were to inform me that esteemed companies like Estee Lauder (EL) or Danaher (DHR) have not only missed their quarterly targets once, but twice, I would have suggested they seek a mental evaluation. These companies are known for consistently surpassing expectations, which is why it is challenging to accurately assess their value at …
In a noteworthy development, the U.S. Food and Drug Administration (FDA) has selected Pfizer, Moderna, and Novavax as the manufacturers for the next round of COVID-19 booster shots. This decision sets the stage for a competitive race among the vaccine makers as they strive to deliver their new jabs by fall. The FDA has advised …
On February 26, 2019, the Chief Executive Officers (CEOs) of prominent pharmaceutical companies appeared before the Senate Finance Committee in Washington, DC for a hearing on “Drug Pricing in America: A Prescription for Change, Part II.” The CEOs in attendance included Richard A. Gonzalez of AbbVie Inc, Pascal Soriot of AstraZeneca, Giovanni Caforio of Bristol-Myers …